AHMEDABAD – In a move to stabilize its leadership following a period of executive turnover, Adline Chem Lab Limited (formerly Kamron Laboratories Ltd) has designated Vrushank Balkrushna Patel as its new Chairman & Managing Director (CMD).
The appointment, approved by the Board of Directors on February 2, 2026, is set to take official effect from February 10, 2026.
Filling the Leadership Void
Patel’s elevation follows the resignation of Sarang Pathak, who stepped down as Executive Director-Chairman (Managing Director) on November 12, 2025.
Timeline of the Transition:
-
April 12, 2025: Vrushank Patel initially joined the board as an Additional Director (Executive, Non-Independent).
-
November 2025: Patel was appointed as Chairman during a broader board restructuring.
-
February 10, 2026: Formally assumes the combined CMD mantle to provide unified leadership.
-
Tenure: His mandate runs through March 4, 2029, completing the remaining term of the previous Managing Director.
Q3 FY26 Financial Review
The leadership change was finalized alongside the review of the company’s standalone unaudited financial results for the quarter ended December 31, 2025.
While the company has faced financial headwinds—reporting a loss before tax of ₹13.89 lakhs for the half-year ended September 2025—the recent restructuring of its Audit and Nomination committees aims to tighten corporate governance.
Company Snapshot
| Metric | Detail |
| BSE Scrip Code | 524604 |
| New CMD | Vrushank Balkrushna Patel |
| Headquarters | Bodakdev, Ahmedabad |
| Sector | Pharmaceuticals & Healthcare |
The Road Ahead
As CMD, Patel’s immediate priority will likely be reversing the stagnant revenue trends noted in recent quarters and leveraging the company’s reclassification of promoter shareholders to improve public market liquidity.
